Regulation of airway fumarate by host and pathogen promotes S. aureus pneumonia

Ying-Tsun Chen1, Zihua Liu2, Dario Fucich1

  • 1Department of Pediatrics, Columbia University, New York, NY 10032, USA.

Insights

Staphylococcus aureus uses the fumC enzyme to metabolize harmful fumarate in the lungs, enabling adaptation and biofilm formation during pneumonia. This adaptation is crucial for survival in the infected airway environment.

Area of Science:

  • Microbiology
  • Immunology
  • Metabolic Adaptation

Background:

  • Staphylococcus aureus is a major cause of hospital-acquired pneumonia.
  • The bacterium must adapt metabolically to survive in the lung's unique environment.
  • Fumarate, a host-produced metabolite, can be detrimental to S. aureus.

Purpose of the Study:

  • Investigate the role of the fumC gene and its product in S. aureus adaptation during pulmonary infection.
  • Determine how S. aureus utilizes fumarate and other host metabolites for survival and virulence.
  • Elucidate the mechanisms by which S. aureus overcomes metabolic challenges in the infected lung.

Main Methods:

  • Analysis of fumC conservation in clinical isolates.
  • In vitro metabolic assays assessing the impact of fumarate on S. aureus pathways.
  • Gene deletion mutant construction and characterization (ΔfumC).
  • In vivo mouse model of Staphylococcus aureus pneumonia.

Main Results:

  • The fumC gene is highly conserved in chronic lung infection isolates.
  • Fumarate accumulation blocks S. aureus glycolysis and oxidative phosphorylation (OXPHOS).
  • Staphylococcal fumarate hydratase (FumC) activity is essential for degrading fumarate and directing its carbon into central metabolic pathways (TCA cycle, gluconeogenesis, hexosamine synthesis).
  • Itaconate enhances FumC activity.
  • A ΔfumC mutant showed significant attenuation in a mouse pneumonia model, especially under fumarate- and itaconate-replete conditions.

Conclusions:

  • Staphylococcus aureus FumC is critical for pulmonary adaptation by metabolizing detrimental fumarate and utilizing it for biosynthesis.
  • Host immunometabolites like fumarate and itaconate shape bacterial adaptation strategies.
  • Targeting FumC or related metabolic pathways could be a novel therapeutic strategy against S. aureus pneumonia.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.6K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
524
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
731
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K